Peer Review Report For: A Comparison Between Treatment Response of Chronic Myeloid Leukemia Patients Receving Imatinib or Nilotinib [version 2; peer review: 1 approved, 1 approved with reservations, 1 not approved]
Fields of Study & Subjects
Chronic Myeloid Leukemia Treatments
Chronic Lymphocytic Leukemia Research
Protein Tyrosine Phosphatases
Publication details
- Journal / source
- F1000Research
- Publication date
- 27 February 2026
- Language
- EN